Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $5
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $5.
Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $5.